Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Conditions: Cutaneous Melanoma; Melanoma Stage IV; Mucosal Melanoma Interventions: Drug: Opdualag; Drug: Nivolumab Sponsors: University Health Network, Toronto Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials